Child and dyadic psychotherapy have been scarcely investigated from the psychotherapy process research perspective. Thus, content and mechanisms related to therapeutic change have been overlooked by research. This study aimed at testing the applicability of the generic change indicators (GCI) model to identify moments of change in the parent during dyadic interventions, as well as to explore, describe and illustrate the therapeutic process through a brief mentalization-informed intervention with a depressive mother and her baby, using video-feedback as its main strategy, which has ample evidence about its effectiveness. We conducted a single case qualitative study using the GCI model. The mother's ongoing change was determined by identifying episodes of change (EC) and moments of change (MC). Each MC was then labelled with one of the 19 GCIs. GCIs were observed from the intervention's start. GCI's hierarchical levels were increasing over the intervention, in association with the video-feedback situation. Our findings suggest that the GCI model is feasible to observe and understand dyadic interventions, contributing to the growing body of evidence supporting psychotherapists' training and supervision.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153750PMC
http://dx.doi.org/10.4081/ripppo.2022.584DOI Listing

Publication Analysis

Top Keywords

gci model
12
generic change
8
change indicators
8
mother baby
8
single case
8
moments change
8
dyadic interventions
8
change
7
outcomes generic
4
indicators video-feedback
4

Similar Publications

Scalable policy adoption and sustainable implementation of surgical care in the Americas.

Rev Panam Salud Publica

December 2024

Corporación Latinoamericana para la Salud Quito, Pichincha Ecuador Corporación Latinoamericana para la Salud, Quito, Pichincha, Ecuador.

On September 29, 2023, the Republic of Ecuador convened a meeting to address surgical system strengthening and urge political leaders to invest in surgical infrastructure. The meeting included experts in health diplomacy, innovative financing, implementation strategy and national surgical plans. The event occurred in parallel with the Sixtieth Directing Council of the Pan American Health Organization, Seventy-fifth session of the World Health Organization Regional Committee for the Americas.

View Article and Find Full Text PDF

Dopamine receptor agonist pramipexole exerts neuroprotection on global cerebral ischemia/reperfusion injury by inhibiting ferroptosis.

J Stroke Cerebrovasc Dis

October 2024

School of Rehabilitation, Capital Medical University, Beijing, China; Beijing Bo'ai hospital, China Rehabilitation Research Center, Beijing, China; Beijing Key Laboratory of Neural Injury and Rehabilitation, Beijing, China. Electronic address:

Objective: To explore the mechanism of dopamine receptor agonist pramipexole in exerting neuroprotection on global cerebral ischemia/reperfusion injury (GCI/R).

Material And Method: Male Sprague-Dawley rats were randomly divided into four groups (n = 36 in each group), and the Pulsinelli's four-vessel occlusion method was used to establish the rat model of GCI/R injury. Pramipexole administration group was intraperitoneally injected with pramipexole 0.

View Article and Find Full Text PDF

Thailand is currently grappling with a severe problem of air pollution, especially from small particulate matter (PM), which poses considerable threats to public health. The speed of the wind is pivotal in spreading these harmful particles across the atmosphere. Given the inherently unpredictable wind speed behavior, our focus lies in establishing the confidence interval (CI) for the variance of wind speed data.

View Article and Find Full Text PDF

Background: Depression in type 2 diabetes mellitus (T2DM) impacts glycemic control and complications. This study examines the influence of depression on compliance with recommended annual diabetes assessments in patients within the Local Healthcare Authority of Romagna. From a clinical health psychology perspective, understanding how depression influences patients' engagement in managing their conditions is crucial.

View Article and Find Full Text PDF
Article Synopsis
  • * The study, called KOMET-001, was conducted in multiple countries and involved dose-escalation and validation phases, with patients in specific molecular subtypes receiving varying doses of ziftomenib over 28-day cycles.
  • * Results indicated that 83 patients were treated with ziftomenib from September 2019 to August 2022, and the findings are crucial for determining the drug's safety and effectiveness for future phases of clinical testing.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!